2. L. F. Gelders and L. M. A. Pintelon, ‘‘Material Handling’’ in R.
C. Dorf and A. Kusiak, eds., Handbook of Design, Manufac-
turing and Automation, Wiley, New York, 1994, Chapter 17.
3. D. R. Sule, Manufacturing Facilities: Location, Planning and
Design, 2nd edition, PWS-Kent Publishing, Boston, MA 1994.
4. F. E. Meyers, Plant Layout and Materials Handling, Regents/
Prentice-Hall, Englewood Cliffs, NJ, 1993.
5. J. A. Tompkins and J. A. White, Facilities Planning, Wiley,
New York, 1984.
6. R. E. Sims, Jr., ‘‘Materials Handling Systems,’’ in G. Salvendy,
ed., Handbook of Industrial Engineering, Wiley, New York,
1982, Chapter 10.3.
7. K. J. Musselman, ‘‘Simulations Spectrum of Power In Manu-
facturing’’ in Proceedings, 1990 IIE Integrated Systems Con-
ference & Society for Integrated Manufacturing Conference,
San Antonio, TX, Oct. 28–31, 1990, pp. 65–70.
8. W. S. Haider and S. Rajan, ‘‘Effective Analysis of Manufactur-
ing Systems Using Appropriate Modeling and Simulation
Tools’’ in Proceedings, 1990 IIE Integrated Systems Confer-
ence & Society for Integrated Manufacturing Conference, San
Antonio, TX, Oct. 28–31, 1990, pp. 94–99.
9. A. M. Law and D. W. Kelton, Simulation Modeling & Analy-
sis, 2nd edition, McGraw-Hill, New York, 1991.
10. CAPE—Computer-Assisted Packaging Evaluation, CAPE
Systems Inc., Plano, TX 75074.
11. TOPS—Total Optimization Packaging Systems, TOPS Engi-
neering Corporation, Plano, TX 75075.
12. R. Muther and K. Haganas, Systematic Handling Analysis,
Management and Industrial Research Publications, Kansas
City, MO, 1975.
13. W. J. Stevenson, Production/Operations Management, 4th
edition, Irwin, Boston, MA 1993.
14. Cimtechnologies Corporation, Factory CAD, Factory Plan &
Factory Flow, Release 3.0 Technical and Reference Manuals,
Ames, IA, 1992.
15. ‘‘Palletizing System Brews up Savings for Miller,’’ Packag.
World, 36 (Dec. 1994).
16. P. Reynolds, ‘‘Empty-Bottle Handling Is No Picnic,’’ Packag.
World 42, 46 (Jan. 1995).
MEDICAL DEVICE PACKAGING
LAURA BIX
JAVIER DE LA FUENTE
School of Packaging,
Michigan State University,
East Lansing, Michigan
INTRODUCTION
Medical devices achieve their therapeutic ends via physi-
cal means, as opposed to metabolic, immunological, or
pharmacological processes. The Global Harmonization
Task Force (GHTF) has proposed the following harmo-
nized definition of a medical device:
Any instrument, apparatus, implement, machine, ap-
pliance, implant in vitro reagent or calibrator, software,
material, or other similar or related article:
a. Intended by the manufacturer to be used, alone or in
combination, for human beings for one or more of the
specific purpose(s) of:
. Diagnosis, prevention, monitoring, treatment, or
alleviation of disease.
. Diagnosis, monitoring, treatment, alleviation of,
or compensation for an injury.
. Investigation, replacement, modification, or sup-
port of the anatomy or of a physiological process.
. Supporting or sustaining life.
. Control of contraception.
. Disinfection of medical devices.
. Providing information for medical or diagnostic
purposes by means of in vitro examination of
specimens derived from the human body, and
b. Which does not achieve its primary intended
action in or on the human body by pharmacological,
immunological, or metabolic means, but which
may be assisted in its intended function by such
means (1).
By definition, devices are involved in many different
aspects of healthcare. As such, devices, their manufac-
turing processes, and the packaging that contains and
protects them are extremely disparate. Complicated
capital equipment, such as MRI tunnels and X-ray ma-
chines, are medical devices, but so are simple, commodity-
like items such as tongue depressors and syringes.
Some are meant for mass markets, others are niche items.
Some are packaged individually; others are packaged
in boxes of 100 s or 1000 s. Some are reprocessed,
others are disposable, and some are used for a lifetime.
Risks associated with device misuse and failures are
equally varied, ranging from inconvenience to patient
death (2).
It is estimated that the medical device and equipment
market will be worth $246 billion by 2011, with a 4.6%
annual growth until that time (3). This is largely driven by
aging populations who frequently engage in active life-
styles, a growing middle class in emerging markets, and
the spread of ‘‘Western diets’’ (4).
A hallmark of the device industry is innovation, which
results in short life cycles for many products. ‘‘Medical
devices undergo constant development based on feedback
from medical practitioners and advances in other sciences
relevant to medical device technology’’ (5). ‘‘With this
constant innovation, the medical device industry spends
heavily on research and development’’ (2); a large portion
of revenues go to R&D streams.
CLASSIFICATION OF MEDICAL DEVICES
The great variation present in the medical device industry
means that devices can be classified in a number of ways.
Devices can be categorized by:
. The risk associated with improper use or a failure
(generally high, moderate, and low).
MEDICAL DEVICE PACKAGING 713